Legal Representation
Attorney
William Anderson
USPTO Deadlines
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 11, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 8, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 11, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 13, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 21, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 20, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 20, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 20, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 25, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 25, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 25, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 19, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 19, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 19, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 19, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Apr 19, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jan 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 19, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 27, 2023 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Feb 17, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 10, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 7, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 27, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 27, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 27, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 26, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 25, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 25, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 11, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 11, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 11, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 25, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 25, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 25, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 22, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 20, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 19, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 15, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials, namely, pliable, synthetic hydrogel; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, pliable, synthetic hydrogel
First Use Anywhere:
Mar 4, 2021
First Use in Commerce:
Mar 4, 2021
Class 010
Embolic devices for treating anomalous vasculature of the body; medical device, namely, arterial embolectomy device; embolic device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; embolic devices for interventional radiology, namely, differentiated liquid embolics; embolic device for vascular embolization procedures; embolic device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; embolic devices, namely, syringes and delivery catheters containing embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in embolization procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical apparatus, namely, system for vascular embolization procedures; embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis, namely, embolization therapy system featuring hydrogel precursors and applicator; kits for vascular embolization procedures, featuring hydrogel precursors and applicator
First Use Anywhere:
Mar 4, 2021
First Use in Commerce:
Mar 4, 2021
Additional Information
Design Mark
The mark consists of stylized word "instylla" with the letter "t" in the form of a wave.
Classification
International Classes
005
010